BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22083004)

  • 1. Coexistent asymptomatic myeloma and hereditary cardiac amyloidosis: an unusual case of heart failure.
    Lee L; Aziz M; Wechalekar A; Rabin N
    Br J Hosp Med (Lond); 2011 Nov; 72(11):650-1. PubMed ID: 22083004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How I treat amyloidosis.
    Comenzo RL
    Blood; 2009 Oct; 114(15):3147-57. PubMed ID: 19617578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis.
    Hamour IM; Lachmann HJ; Goodman HJ; Petrou M; Burke MM; Hawkins PN; Banner NR
    Am J Transplant; 2008 May; 8(5):1056-9. PubMed ID: 18318779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant.
    Ono R; Takahashi H; Sato T; Yamazaki T; Hori Y; Fukushima K
    J Cardiol Cases; 2020 Nov; 22(5):221-225. PubMed ID: 33133314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family.
    Booth DR; Tan SY; Hawkins PN; Pepys MB; Frustaci A
    Circulation; 1995 Feb; 91(4):962-7. PubMed ID: 7850982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from Val30Met mutation with no clinical signs of polyneuropathy.
    Christoph DC; Boese D; Johnson KT; Schlosser TW; Hunold P; Baba HA; Erbel R; Philipp S
    Circ Heart Fail; 2009 Sep; 2(5):512-5. PubMed ID: 19808383
    [No Abstract]   [Full Text] [Related]  

  • 8. Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure.
    Molina O G; Judge D; Campbell W; Chahal H; Mugmon M
    J Community Hosp Intern Med Perspect; 2014; 4(5):25500. PubMed ID: 25432650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral periorbital ecchymoses. An often missed sign of amyloid purpura.
    Colucci G; Alberio L; Demarmels Biasiutti F; Lämmle B
    Hamostaseologie; 2014; 34(3):249-52. PubMed ID: 24975676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins.
    Comenzo RL; Zhou P; Fleisher M; Clark B; Teruya-Feldstein J
    Blood; 2006 May; 107(9):3489-91. PubMed ID: 16439680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic approach to cardiac amyloidosis.
    Amin HZ; Mori S; Sasaki N; Hirata K
    Kobe J Med Sci; 2014 Jun; 60(1):E5-E11. PubMed ID: 25011639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.
    Carr AS; Pelayo-Negro AL; Jaunmuktane Z; Scalco RS; Hutt D; Evans MR; Heally E; Brandner S; Holton J; Blake J; Whelan CJ; Wechalekar AD; Gillmore JD; Hawkins PN; Reilly MM
    Neuromuscul Disord; 2015 Jun; 25(6):511-5. PubMed ID: 25819286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
    Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
    J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexplained cardiac failure leading to the identification of a Belgian family affected by hereditary amyloidosis.
    De Pasqual A; Biessaux Y; Blettard N; Crémers S; Caers J
    Acta Clin Belg; 2013; 68(4):303-5. PubMed ID: 24455802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
    Ihse E; Ybo A; Suhr O; Lindqvist P; Backman C; Westermark P
    J Pathol; 2008 Oct; 216(2):253-61. PubMed ID: 18729067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma.
    Carrizales-Sepúlveda EF; Ordáz-Farías A; Vera-Pineda R; Benavides-González MA; Flores-Ramírez R
    Am J Case Rep; 2017 Jul; 18():790-793. PubMed ID: 28701686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial approach in hereditary transthyretin cardiac amyloidosis].
    García-Pavía P; Avellana P; Bornstein B; Heine-Suñer D; Cobo-Marcos M; Gómez-Bueno M; Segovia J; Alonso-Pulpón LA
    Rev Esp Cardiol; 2011 Jun; 64(6):523-6. PubMed ID: 21439703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.
    Fradley MG; Thakuria JV; Collins AB; Moore SA; Stone JR
    Tex Heart Inst J; 2012; 39(1):71-5. PubMed ID: 22412233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial amyloid cardiomyopathy masquerading as chronic Guillain-Barre syndrome: things are not always what they seem.
    Hu D; Liu L; Yuan S; Yi Y; Peng D
    Front Med; 2017 Jun; 11(2):293-296. PubMed ID: 28425041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.